Recent solubility and dissolution enhancement techniques for repaglinide a BCS class II drug: a review
Repaglinide is an oral blood-glucose-lowering drug used to manage type-2 diabetes mellitus by lowering post-prandial glucose by stimulating insulin secretion from pancreatic beta cells. According to the biopharmaceutical classification system, repaglinide falls under the class II category. For such...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Pensoft Publishers,
2021-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|